Drugs: Prices

Department of Health and Social Care written question – answered at on 22 October 2020.

Alert me about debates like this

Photo of Anne Marie Morris Anne Marie Morris Conservative, Newton Abbot

To ask the Secretary of State for Health and Social Care, what steps his Department has taken to respond to concerns raised by the Competition and Markets Authority on the pricing of (a) hydrocortisone tablets and (b) liothyronine tablets since 2016.

Photo of Jo Churchill Jo Churchill The Parliamentary Under-Secretary for Health and Social Care

Concerns about potential drug pricing abuses are a matter for the Competition and Markets Authority (CMA). The CMA has several ongoing investigations into excessive prices of generic medicines. Where it has concern about the price of a generic medicine, the Department asks the CMA to investigate that price.

Does this answer the above question?

Yes1 person thinks so

No23 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.